When stratified by timing of treatment initiation , in participants enrolled @ h or longer since illness onset , the median duration of symptoms was similar in both groups ( oseltamivir @ days -LSB- IQR @-@ -RSB- , placebo @ days -LSB- @-@ -RSB- ; p = @ ) .